Motofumi Tanaka, Taro Okazaki, Hideo Suzuki, James L. Abbruzzese and Donghui Li Association of multi-drug resistance gene polymorphisms with pancreatic cancer outcome Cancer 117
Version of Record online: 4 OCT 2010 | DOI: 10.1002/cncr.25510
In this study, we demonstrated that polymorphic variants of drug resistance genes MRP5 and MRP2 are associated with tumor response to gemcitabine-based chemoradiotherapy and overall survival in patients with potentially resectable pancreatic cancer. This information has the potential to help with treatment selection for individualized therapy of pancreatic cancer.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field